Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.

Saito Y, Morimoto T, Ogawa H, Nakayama M, Uemura S, Doi N, Jinnouchi H, Waki M, Soejima H, Sugiyama S, Okada S, Akai Y; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes Trial Investigators.

Diabetes Care. 2011 Feb;34(2):280-5. doi: 10.2337/dc10-1615.

2.

Aspirin for primary prevention of atherosclerotic disease in Japan.

Morimoto T, Nakayama M, Saito Y, Ogawa H.

J Atheroscler Thromb. 2007 Aug;14(4):159-66. Epub 2007 Aug 29. Review.

3.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
4.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

5.

[Aspirin in primary prevention of ischemic heart disease].

Preobrazhenskiń≠ DV, Sidorenko BA, Malysheva NV, Tsurko VV.

Kardiologiia. 2002;42(4):91-5. Review. Russian.

PMID:
12494176
6.

Does aspirin cause acute or chronic renal failure in experimental animals and in humans?

D'Agati V.

Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S24-9. Review.

PMID:
8669425

Supplemental Content

Support Center